But heres whats often left out of the conversation: Your body already makes its own GLP-1s
Tirzepatide and retatrutide are also glucose-dependent insulinotropic polypeptide (GIP) agonists
The small-molecule non-peptide GLP-1 agonists segment is estimated to be the fastest-growing in the global oral GLP-1 market due to its high oral bioavailability, ease of manufacturing, and potential for cost-effective production
Patients with risk factors for pancreatitis, gallbladder disease, or significant diabetic retinopathy require particular attention during treatment
If you eat before taking your pill, the absorption enhancer will not work, and the medication will likely be destroyed by your stomach acids
On January 17, 2025, the EMA also started a review on the potential association between semaglutide and non-arteritic anterior ischemic optic neuropathy [148]